Amla / Indian Gooseberry Benefits

Amla — the fruit of Phyllanthus emblica, sold as Indian gooseberry, amalaki, aonla, nellikai and yu gan zi — is one of the few herbal products on this site with a genuine claim to being a food first and a supplement second. People eat it fresh with salt. They pickle it, candy it, juice it and cook it into chyawanprash. It is one of the three fruits of Triphala, alongside haritaki and baheda. And it carries a reputation for vitamin C so large that it has stopped being a measurement and become a slogan.

These four articles go underneath the slogan. The short version, before you read any of them: amla is a real vitamin C food whose famous number is smaller and much less certain than advertised; it has better human trial evidence than most herbs and that evidence is still thin, short and geographically lopsided; and its most reliably demonstrated benefit is one almost nobody mentions — what a Triphala mouthwash does to dental plaque.

Table of Contents

  1. Deep-Dive Articles
  2. Where the Evidence Is Strong — and Where It Is Not
  3. What Each Form Actually Delivers
  4. The Geography Problem
  5. The One Interaction Everybody Skips
  6. Key Research Papers
  7. External Resources
  8. Connections

Deep-Dive Articles

Four articles, in the order that makes the rest make sense. Start with the chemistry — almost every other claim about amla is downstream of it.

Vitamin C and Antioxidant Chemistry

Why the quoted vitamin C figures range from 250 to 900 mg per 100 g, what a specific HPLC method found instead, and the analytical paper that could not find the antioxidant molecules amla is supposedly famous for.

Cholesterol and Metabolic Health

Five small randomised trials, one meta-analysis, one head-to-head against simvastatin with a design worth reading carefully, and one European trial that found nothing. What the numbers support and what they do not.

Hair, Skin and Traditional Cosmetic Use

Amla hair oil is a real tradition with one modern randomised trial behind it. What that trial measured, why an enzyme screen in rat liver is not a scalp result, and the widely cited skin paper that used the branch rather than the fruit.

Triphala and Digestive Use

What amla contributes to the three-fruit formula, the reflux trial, the microbiome claims and their actual evidence level, the strongest Triphala result on the page — a mouthwash — and the tannin-and-iron problem in detail.

Where the Evidence Is Strong — and Where It Is Not

An honest map before you read anything else. “Human RCT” here means a randomised controlled trial in people; “lab” means cell culture or animals, which tells you about mechanism and nothing about whether a capsule works.

UseBest available evidenceHonest verdict
Triphala mouthwash for plaque and gum inflammationSeveral human RCTs plus a systematic review and meta-analysis, mostly against chlorhexidineThe best-supported use of any amla-containing product — and the one nobody markets
Cholesterol and triglyceridesFive small human RCTs, pooled in one 2023 meta-analysis; largest single trial n = 98 for 12 weeksA real, consistent signal on blood markers. Short trials, small samples, no outcome data on heart attacks or strokes
Fasting blood glucosePooled reduction in the same meta-analysis; one uncontrolled dose-ranging study in PakistanPlausible and worth monitoring for, especially if you take diabetes medication. Not a treatment
Endothelial function, hsCRP, oxidative-stress markersTwo human RCTs from one Hyderabad groupSurrogate markers, single centre. Interesting, not established
Blood pressureOne add-on RCT in treated hypertensionAdd-on only. Never a replacement for antihypertensive medication
Non-erosive reflux (heartburn without visible damage)One 68-patient RCT from TehranOne trial, one centre, never replicated. A reasonable thing to try, not a proven treatment
Female pattern hair lossOne triple-blind RCT, 60 women, 12 weeks, amla syrupPositive on a hair-cycle ratio and on satisfaction scores. A single small trial
Skin ageing, collagen, photoprotectionHuman skin fibroblasts in culture; one clinical cosmetic study of the branch extractLaboratory-stage. No trial of amla fruit on human skin ageing
“Antioxidant” and “immunity” claims generallyAssay numbers, animal models, marketingThe weakest ground on this page. See the chemistry article for why the assay numbers themselves are contested

What Each Form Actually Delivers

“Amla” on a label can mean six different things that behave differently in your body and were tested in different studies — or in no study at all. The trial results do not transfer between them.

FormWhat it deliversWas it what the trials used?
Fresh fruitThe full package: ascorbic acid, tannins, fibre, water. The only form that reliably delivers meaningful vitamin CNo. No modern RCT used fresh fruit
Dried fruit powder (churna)Tannins survive drying well; ascorbic acid content varies enormously with drying method and storageThe Pakistani glucose study used 1–3 g/day of powder — but without a placebo group
JuiceHighly variable. Frequently diluted and sugared; check the label for bothNo
Standardised extract capsuleConcentrated polyphenols; usually little vitamin C. 500 mg twice daily is the studied doseYes — this is the form behind essentially all the lipid, glucose and blood-pressure results
Triphala churnaRoughly one-third amla by weight, plus haritaki and baheda. Typically 3–6 g at nightOnly for the mouthwash and the negative cholesterol trial
ChyawanprashCooked amla in a jam that is largely sugar by weightOne 2001 Indian study on glucose tolerance and lipoproteins. Count it as a sweet
Amla hair oilTopical, traditional, and outside every trial on this page except by analogyNo. The hair trial used an oral syrup

The single most useful sentence on this page: if you want vitamin C, eat the fruit; if you want the trial results, take the extract; the two are not substitutes for each other.

The Geography Problem

Something worth naming plainly, because it recurs in every one of the four articles.

Almost the entire positive clinical literature on amla comes from a small number of centres in one country, with a handful of research groups appearing repeatedly across the lipid, endothelial and blood-pressure trials. Several of the trials were registered after they started. Sample sizes run from 10 to 98. Follow-up runs from three to twelve weeks.

None of that makes the results wrong. Indian research groups study Indian medicinal plants for obvious and legitimate reasons, and expecting them not to would be absurd. But there is a well-documented pattern in complementary-medicine research in which effect sizes shrink sharply once a treatment is tested outside the country that developed it — and amla has one such test. In 2021, Donato and colleagues in Brescia, Italy ran a placebo-controlled, double-blind trial of a guggul-plus-Triphala preparation in 90 people with high cholesterol for three months. It found no benefit over placebo on total cholesterol, LDL cholesterol, BMI or waist circumference — and 4.3% of the treated group developed a hypersensitivity rash, against none on placebo.

That was a different product and a different combination from the amla extracts that produced the positive results, so it is not a direct refutation. It is something more useful: a demonstration of what happens when one of these preparations meets an independent European trial team. Hold the positive results at exactly that much arm's length.

The One Interaction Everybody Skips

Amla is rich in galloyl-group tannins — gallic acid, ellagic acid, the disputed emblicanins, and the mucic acid gallates identified in 2009. This chemistry is why it tastes astringent, and it is also why it interferes with iron.

The anchor study is not about amla at all. In 1989, Brune, Rossander and Hallberg in Göteborg measured non-haem iron absorption in humans against measured amounts of different phenolic structures, and found the inhibition was strongly dose-related and specific to galloyl groups: 5 mg of tannic acid cut iron absorption by 20%, 25 mg by 67%, and 100 mg by 88%. Catechol-type phenolics did nothing; condensed tannins did not interfere. It is the galloyl group that matters — and galloyl groups are exactly what amla and Triphala are full of.

Amla complicates its own story, because it also contains ascorbic acid, which strongly enhances non-haem iron absorption. Within the whole fresh fruit those two effects push in opposite directions and nobody has measured the net result directly. In a tannin-rich extract with little vitamin C, assume the inhibition wins. If you are anaemic, iron-deficient, pregnant, a regular blood donor, a heavy menstruater or vegetarian, this matters more than anything else on this page: take amla or Triphala at least two hours away from iron-containing meals and iron supplements, and mention it if your ferritin is being monitored.

Key Research Papers

Every identifier below was checked live against NCBI E-utilities before it was printed — first author, title, journal and year all had to match. Where a paper could not be confirmed that way, the entry carries a PubMed topic search instead of a number that might point at the wrong study.

The vitamin C and antioxidant chemistry

  1. Scartezzini P, Antognoni F, Raggi MA, Poli F, Sabbioni C. Vitamin C content and antioxidant activity of the fruit and of the Ayurvedic preparation of Emblica officinalis Gaertn. Journal of Ethnopharmacology. 2006;104(1–2):113–118. Specific HPLC-DAD: 0.4% ascorbic acid in raw fruit, 1.28% after traditional processing.
  2. Majeed M, Bhat B, Jadhav AN, Srivastava JS, Nagabhushanam K. Ascorbic acid and tannins from Emblica officinalis Gaertn. fruits — a revisit. Journal of Agricultural and Food Chemistry. 2009;57(1):220–225. Found no evidence of emblicanins A and B; identified co-eluting mucic acid gallates.
  3. Levine M, Conry-Cantilena C, Wang Y, et al. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proceedings of the National Academy of Sciences. 1996;93(8):3704–3709. Human depletion–repletion study; the basis of modern vitamin C requirements.
  4. Carlsen MH, Halvorsen BL, Holte K, et al. The total antioxidant content of more than 3100 foods, beverages, spices, herbs and supplements used worldwide. Nutrition Journal. 2010;9:3. The scale of assay-based food antioxidant rankings — and their limits.

Lipids, glucose and metabolic markers in humans

  1. Setayesh L, Haghighat N, Rasaei N, et al. The impact of Emblica officinalis (Amla) on lipid profile, glucose, and C-reactive protein: a systematic review and meta-analysis of randomized controlled trials. Diabetes & Metabolic Syndrome. 2023;17(3):102729. Five RCTs pooled; interventions 3–12 weeks.
  2. Upadya H, Prabhu S, Prasad A, Subramanian D, Gupta S, Goel A. A randomized, double blind, placebo controlled, multicenter clinical trial to assess the efficacy and safety of Emblica officinalis extract in patients with dyslipidemia. BMC Complementary and Alternative Medicine. 2019;19(1):27. Human RCT, n = 98, 500 mg twice daily for 12 weeks.
  3. Gopa B, Bhatt J, Hemavathi KG. A comparative clinical study of hypolipidemic efficacy of Amla (Emblica officinalis) with 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitor simvastatin. Indian Journal of Pharmacology. 2012;44(2):238–242. 60 patients, 42 days, no placebo group — read the design.
  4. Akhtar MS, Ramzan A, Ali A, Ahmad M. Effect of Amla fruit (Emblica officinalis Gaertn.) on blood glucose and lipid profile of normal subjects and type 2 diabetic patients. International Journal of Food Sciences and Nutrition. 2011;62(6):609–616. Uncontrolled dose-ranging study from Pakistan; comparisons are against baseline, not placebo.
  5. Donato F, Raffetti E, Toninelli G, Festa A, Scarcella C, Castellano M. Guggulu and Triphala for the treatment of hypercholesterolaemia: a placebo-controlled, double-blind, randomised trial. Complementary Medicine Research. 2021;28(3):216–225. Human RCT, n = 90, 3 months — negative, with 4.3% hypersensitivity rash.

Endothelial function, blood pressure and platelets

  1. Usharani P, Merugu PL, Nutalapati C. Evaluation of the effects of a standardized aqueous extract of Phyllanthus emblica fruits on endothelial dysfunction, oxidative stress, systemic inflammation and lipid profile in subjects with metabolic syndrome. BMC Complementary and Alternative Medicine. 2019;19(1):97. Human RCT, n = 59, 250 and 500 mg twice daily.
  2. Usharani P, Fatima N, Muralidhar N. Effects of Phyllanthus emblica extract on endothelial dysfunction and biomarkers of oxidative stress in patients with type 2 diabetes mellitus: a randomized, double-blind, controlled study. Diabetes, Metabolic Syndrome and Obesity. 2013;6:275–284. Human RCT.
  3. Shanmugarajan D, Girish C, Harivenkatesh N, Chanaveerappa B, Prasanna Lakshmi NC. Antihypertensive and pleiotropic effects of Phyllanthus emblica extract as an add-on therapy in patients with essential hypertension. Phytotherapy Research. 2021;35(6):3275–3285. Human RCT, add-on design.
  4. Fatima N, Pingali U, Muralidhar N. Study of pharmacodynamic interaction of Phyllanthus emblica extract with clopidogrel and ecosprin in patients with type II diabetes mellitus. Phytomedicine. 2014;21(5):579–585. Human crossover, n = 10 — significant antiplatelet activity alone and in combination. The basis of the bleeding caution.

Triphala, the mouth and the gut

  1. Peterson CT, Denniston K, Chopra D. Therapeutic uses of Triphala in Ayurvedic medicine. Journal of Alternative and Complementary Medicine. 2017;23(8):607–614. Review.
  2. AlJameel AH, Almalki SA. Effect of triphala mouthrinse on plaque and gingival inflammation: a systematic review and meta-analysis of randomized controlled trials. International Journal of Dental Hygiene. 2020;18(4):344–351. The strongest evidence base on this page.
  3. Pradeep AR, Suke DK, Martande SS, et al. Triphala, a new herbal mouthwash for the treatment of gingivitis: a randomized controlled clinical trial. Journal of Periodontology. 2016;87(11):1352–1359. Human RCT.
  4. Karkon Varnosfaderani S, Hashem-Dabaghian F, Amin G, et al. Efficacy and safety of Amla (Phyllanthus emblica L.) in non-erosive reflux disease: a double-blind, randomized, placebo-controlled clinical trial. Journal of Integrative Medicine. 2018;16(2):126–131. Human RCT, n = 68, 4 weeks.
  5. Peterson CT, Sharma V, Uchitel S, et al. Prebiotic potential of herbal medicines used in digestive health and disease. Journal of Alternative and Complementary Medicine. 2018;24(7):656–665. In vitro faecal culture — not a human microbiome trial.

Hair, skin, iron and product quality

  1. Akhbari M, Firooz A, Rahimi R, Shirzad M, Esmaealzadeh N, Shirbeigi L. The effect of an oral product containing Amla fruit (Phyllanthus emblica L.) on female androgenetic alopecia: a randomized controlled trial. Journal of Ethnopharmacology. 2024;318(Pt A):116958. Triple-blind human RCT, 60 women, 12 weeks.
  2. Fujii T, Wakaizumi M, Ikami T, Saito M. Amla (Emblica officinalis Gaertn.) extract promotes procollagen production and inhibits matrix metalloproteinase-1 in human skin fibroblasts. Journal of Ethnopharmacology. 2008;119(1):53–57. Cell culture.
  3. Brune M, Rossander L, Hallberg L. Iron absorption and phenolic compounds: importance of different phenolic structures. European Journal of Clinical Nutrition. 1989;43(8):547–557. Human absorption study — galloyl groups are the determinant; 25 mg tannic acid cut absorption 67%.
  4. Saper RB, Phillips RS, Sehgal A, et al. Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet. JAMA. 2008;300(8):915–923. Why third-party heavy-metal testing is a real question for imported products.
  5. Hegde SN, K LD, Choudhary M, Menon N, Singh G. A comprehensive metabolome profiling of Terminalia chebula, Terminalia bellerica, and Phyllanthus emblica to explore the medicinal potential of Triphala. Scientific Reports. 2024;14(1):31635.

Live PubMed Searches

  1. Phyllanthus emblica
  2. Emblica officinalis (the synonym)
  3. Amla randomised trials
  4. Triphala
  5. Emblicanin A and B
  6. Chyawanprash
  7. Tannins and non-haem iron absorption
  8. Ayurvedic products and heavy metals

External Resources

Connections

Back to Table of Contents